Skip to main content
. 2012 Jul 11;2012(7):CD006534. doi: 10.1002/14651858.CD006534.pub2

Thomas 2008.

Methods Twelve‐week, multi‐centred randomised controlled trial.
Participants Patients with depression according to ICD‐10 criteria, recruited in primary care setting.
Interventions Citalopram dose range: 20 mg/day.
Reboxetine dose range: 8 mg/day.
Outcomes Change in Beck Depression Inventory (BDI) from baseline to week 6.
Notes Only study protocol available.